Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 28:9:627816.
doi: 10.3389/fcell.2021.627816. eCollection 2021.

Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)

Affiliations

Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)

Marcin Orzechowski et al. Front Cell Dev Biol. .

Abstract

Research with induced pluripotent stem cells (iPSCs) involves specific ethical challenges, which should be addressed in the informed consent process. Up to now, little concern has been paid to the practice of information in iPSC-clinical studies. In order to fill this research gap, we have searched the documentation of the Research Ethics Committee at Ulm University from the years 2007 to 2019. In our previous research, we have identified 11 items for evaluation of the process of information in iPSC research. We used these items to analyze content and form of information provided for participants in the iPSC studies conducted at Ulm University and Ulm University Hospital in Germany. All analyzed studies provide general information regarding the study's aim, method, and collection of donor's personal data and specimen. The information for participants in these studies adheres to general guidelines for research involving human subjects; however, in several areas fails to take into account the specific nature of research with iPSCs. The majority of analyzed studies fail to provide information about possible individual consequences connected with genetic research, such as the possibility of re-identification of the donor or incidental findings acquired during research. Missing is also information about the possibility of future studies involving reproductive research or transplantation of cells and organs. The donor information process in all analyzed studies is conducted in form of the information sheet and oral information. The results of our research show that the process of informed consent in iPSC research should be updated as new developments emerge in this area. However, comprehension of information should not be jeopardized through information overload. Effective communication of essential information requires improved information methods tailored to the needs of participants, such as video animations, interactive consent modules or social media instruments.

Keywords: clinical research; clinical translation; ethics; induced pluripotent stem cells; informed consent.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Aalto-Setälä K., Conklin B. R., Lo B. (2009). Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol. 24:e42. 10.1371/journal.pbio.1000042 - DOI - PMC - PubMed
    1. Avior Y., Sagi I., Benvenisty N. (2016). Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17 170–182. 10.1038/nrm.2015.27 - DOI - PubMed
    1. Bergman K., Graff G. D. (2007). The global stem cell patent landscape: implications for efficient technology transfer and commercial development. Nature Biotechnology 25 419–424. 10.1038/nbt0407-419 - DOI - PubMed
    1. Beskow L. M., Friedman J. Y., Hardy N. C. (2010). Simplifying informed consent for biorepositories: stakeholder perspectives. Genet. Med. 12 567–572. 10.1097/gim.0b013e3181ead64d - DOI - PMC - PubMed
    1. Blau H. M., Daley G. Q. (2019). Stem cells in the treatment of disease. N. Engl. J. Med. 380 1748–1760. - PubMed

LinkOut - more resources